Treatment with Hemlibra (emicizumab) can help to effectively manage bleeding in individuals with acquired hemophilia A (AHA), according…
Articles by Marisa Wexler, MS
The investigational medication marzeptacog alfa activated (MarzAA) showed promise at stopping bleeding in animal models of hemophilia. The findings were…
Eloctate can induce immune tolerance in people with hemophilia A more quickly than other regimens, a study suggests.
A mechanism largely left unexplored was shown to help regulate factor VIII (FVIII) — the clotting protein that is missing…
Roctavian, an investigational gene therapy, significantly reduced bleeding rates and the need for other treatments in men with…
Note: This story was updated Jan. 8, 2021, to clarify that the second set of experiments in mice and non-human…
Prime Therapeutics and Takeda will work together to establish the value of Advate, relative to its costs and…
Funding has been set for the RESET-HA Phase 3 clinical trial evaluating Tremeau Pharmaceuticals‘ TRM-201 (rofecoxib) in people with…
Dosing has been resumed in ongoing clinical trials in the U.S. testing the investigational medication fitusiran in adults and adolescents…
A web-based software to help personalize dosing regimens for hemophilia A patients being treated with Adynovate is now…